Capital International’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-50,926
| Closed | -$3.36M | – | 148 |
|
|
2024
Q3 | $3.36M | Hold |
50,926
| – | – | 0.14% | 115 |
|
|
2024
Q2 | $4.7M | Sell |
50,926
-39
| -0.1% | -$3.6K | 0.22% | 100 |
|
|
2024
Q1 | $4.87M | Sell |
50,965
-4,852
| -9% | -$464K | 0.23% | 100 |
|
|
2023
Q4 | $4.26M | Sell |
55,817
-73,472
| -57% | -$5.6M | 0.22% | 110 |
|
|
2023
Q3 | $8.96M | Sell |
129,289
-639
| -0.5% | -$44.3K | 0.52% | 66 |
|
|
2023
Q2 | $12.3M | Buy |
129,928
+162
| +0.1% | +$15.3K | 0.69% | 53 |
|
|
2023
Q1 | $10.7M | Buy |
129,766
+6,112
| +5% | +$506K | 0.64% | 57 |
|
|
2022
Q4 | $9.23M | Buy |
123,654
+5,487
| +5% | +$409K | 0.64% | 62 |
|
|
2022
Q3 | $9.76M | Buy |
118,167
+12,087
| +11% | +$999K | 0.68% | 47 |
|
|
2022
Q2 | $10.1M | Buy |
106,080
+1,952
| +2% | +$186K | 0.76% | 37 |
|
|
2022
Q1 | $12.3M | Buy |
104,128
+213
| +0.2% | +$25.1K | 0.7% | 40 |
|
|
2021
Q4 | $13.5M | Sell |
103,915
-711
| -0.7% | -$92.1K | 0.68% | 37 |
|
|
2021
Q3 | $11.8M | Sell |
104,626
-1,237
| -1% | -$140K | 0.64% | 43 |
|
|
2021
Q2 | $11M | Buy |
105,863
+12,100
| +13% | +$1.25M | 0.6% | 45 |
|
|
2021
Q1 | $7.84M | Buy |
93,763
+4,857
| +5% | +$406K | 0.47% | 63 |
|
|
2020
Q4 | $8.11M | Hold |
88,906
| – | – | 0.47% | 60 |
|
|
2020
Q3 | $7.1M | Buy |
88,906
+17,857
| +25% | +$1.43M | 0.48% | 56 |
|
|
2020
Q2 | $4.91M | Sell |
71,049
-252
| -0.4% | -$17.4K | 0.46% | 57 |
|
|
2020
Q1 | $4.48M | Buy |
+71,301
| New | +$4.48M | 0.5% | 53 |
|